Peter J. Blott, EVP & CFO at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), bought 4,100 shares at $18.24 ($75K) on 2008-11-14, disclosed to the SEC on 2008-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.